Science MMAI Gym
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- Insilico Medicine reports 2026 first-half profitability and AI pipeline progress
Insilico Medicine announced profitability in the first half of 2026, according to a 36Kr report. The report says 35 pipeline assets developed with its generative-AI platform, Pharma.AI, reached preclinical candidate compound status, while disclosed business-development cooperation involving its AI platform and pipeline totaled US$11 billion. In the interview, co-CEO Ren Feng said 70%–80% of the company’s code is written by AI and that AI now has substantial weight in drug-development decisions. He also said automated laboratories still require manual validation and calibration before experiments can be run, and that current technology is insufficient for a fully autonomous research loop.
36氪 人工智能 · 🔥 0
Experience and discussion from the community
Share my Science MMAI Gym experienceAsk about Science MMAI Gym
Nobody has shared their experience with Science MMAI Gym yet.